AOD-9604 vs HGH Fragment 176-191
A detailed comparison to help you understand the differences and choose the right peptide for your research.
AOD-9604 and HGH Fragment 176-191 are closely related peptides that target fat metabolism. In fact, AOD-9604 is essentially Fragment 176-191 with an additional tyrosine modification. Understanding their subtle differences helps choose the right fat-loss peptide.
Quick Comparison
Key Similarities
- Both target fat metabolism specifically
- Both stimulate lipolysis and inhibit lipogenesis
- Both have no effect on blood glucose
- Both cause no growth effects
- Both use similar dosing protocols
- Both work independently of GH receptor
Key Differences
- AOD-9604 has additional tyrosine for stability
- AOD-9604 has more formal clinical research
- AOD-9604 has FDA GRAS status
- Fragment 176-191 may be less expensive
- AOD-9604 may have slightly better bioavailability
- Fragment 176-191 is the 'pure' sequence
When to Choose Each
Choose AOD-9604
Choose AOD-9604 when you want the more researched version with FDA GRAS status. Its tyrosine modification may provide better stability and the additional clinical data offers more confidence.
Choose HGH Fragment 176-191
Choose HGH Fragment 176-191 when you prefer the pure, unmodified sequence or when cost is a significant factor. Effects are essentially equivalent to AOD-9604.
Can You Stack Them?
Using both together is unnecessary as they're nearly identical. Either can be combined with GH secretagogues for complementary effects—secretagogues for GH benefits, fragments for targeted fat loss.
Frequently Asked Questions
References
- Heffernan M, et al. "AOD9604 lipolytic effects." Obesity Research, 2003. PMID: 12972680
- Ng FM, et al. "GH fragment fat metabolism." J Endocrinol, 2000. PMID: 10801956
Get the Complete Comparison Guide
Download our detailed comparison charts and decision framework.